Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.22 USD | +0.29% | -2.46% | -29.24% |
09-04 | Azenta Names John Marotta CEO | MT |
09-04 | Azenta, Inc. Announces Management Changes | CI |
Chart calendar Azenta, Inc.
Upcoming events on Azenta, Inc.
Past events on Azenta, Inc.
2024-08-11 | Needham Virtual MedTech & Diagnostics 1x1 Conference |
2024-08-06 16:30 | Q3 2024 Earnings Call |
2024-08-06 16:05 | Q3 2024 Earnings Release |
2024-06-05 11:00 | Jefferies Global Healthcare Conference |
2024-05-08 16:30 | Q2 2024 Earnings Call |
2024-05-08 16:05 | Q2 2024 Earnings Release |
2024-04-08 12:45 | Needham Healthcare Conference |
2024-03-19 12:45 | KeyBanc Life Sciences & MedTech Forum |
2024-03-14 09:00 | Investor Day |
2024-02-07 16:30 | Q1 2024 Earnings Call |
2024-02-07 16:05 | Q1 2024 Earnings Release |
2024-02-05 12:00 | Society for Laboratory Automation and Screening International Conference |
2024-01-30 10:00 | Annual General Meeting |
2024-01-18 10:15 | Needham Growth Conference |
2024-01-11 10:30 | JPMorgan Healthcare Conference |
2023-11-28 | Evercore ISI HealthCONx Conference |
2023-11-16 12:00 | Stephens Investment Conference |
2023-11-13 16:30 | Q4 2023 Earnings Call |
2023-11-13 16:07 | Q4 2023 Earnings Release |
2023-09-13 14:55 | Morgan Stanley Global Healthcare Conference |
Past dividends on Azenta, Inc.
2021-12-01 | Quarterly 0.1 USD |
2021-09-01 | Quarterly 0.1 USD |
2021-06-02 | Quarterly 0.1 USD |
2021-03-03 | Quarterly 0.1 USD |
2020-12-02 | Quarterly 0.1 USD |
2020-09-02 | Quarterly 0.1 USD |
2020-06-03 | Quarterly 0.1 USD |
2020-03-04 | Quarterly 0.1 USD |
2019-12-04 | Quarterly 0.1 USD |
2019-09-04 | Quarterly 0.1 USD |
2019-06-05 | Quarterly 0.1 USD |
2019-02-27 | Quarterly 0.1 USD |
2018-12-05 | Quarterly 0.1 USD |
2018-09-05 | Quarterly 0.1 USD |
2018-05-30 | Quarterly 0.1 USD |
2018-02-28 | Quarterly 0.1 USD |
2017-11-29 | Quarterly 0.1 USD |
2017-09-06 | Quarterly 0.1 USD |
2017-05-30 | Quarterly 0.1 USD |
2017-02-28 | Quarterly 0.1 USD |
Annual results
Fiscal Period | September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 194 1 188 0.48% | 555 552 0.69% | 665 656 1.44% | 656 | 703 | 755 |
EBITDA Million USD | Released Forecast Spread | 246 298 -17.53% | 62,5 64,3 -2.77% | 30,4 26,8 13.32% | 49,9 | 75,6 | 112 |
EBIT Million USD | Released Forecast Spread | 180 240 -24.9% | 28,5 25,8 10.28% | -15,3 -22,3 31.52% | -8,39 | 16,2 | 47,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -49,0 157 -131.15% | -9,94 -12,7 21.82% | -30,4 -37,0 17.69% | -164 | -24,3 | 9,70 |
Net income Million USD | Released Forecast Spread | 111 125 -11.33% | 2 133 2 149 -0.76% | -14,3 -27,4 47.93% | -163 | -23,4 | 1,82 |
EPS USD | Released Forecast Spread | 1,49 1,71 -12.87% | 28,5 7,03 304.98% | -0,22 -0,40 44.72% | -3,05 | -0,58 | -0,08 |
Announcement Date | 10/11/21 | 14/11/22 | 13/11/23 | - |
Quarterly results
Fiscal Period | Juni | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 138 134 2.87% | 178 181 -1.65% | 148 162 -8.34% | 166 153 8.23% | 172 164 5.16% | 154 151 2.09% | 159 160 -0.46% | 173 166 4.32% | 169 | 170 | 167 | 178 | 183 | 194 | 179 | 188 |
EBITDA Million USD | Released Forecast Spread | 9,45 8,30 13.87% | 12,0 14,2 -15.9% | -2,40 1,02 -334.91% | 12,9 0,30 4235.07% | 7,94 4,16 91.01% | 4,56 0,40 1047.36% | 9,44 7,26 30.04% | 17,9 12,2 46.69% | 18,0 | 18,2 | 16,6 | 19,5 | 20,8 | 25,9 | 24,7 | 30,3 |
EBIT Million USD | Released Forecast Spread | 2,07 0,00 - | -0,04 4,97 -100.81% | -13,3 -11,4 -16.42% | -1,06 -12,7 91.67% | -0,90 -7,95 88.73% | -8,71 -12,9 32.43% | -5,74 -6,90 16.85% | 4,58 -1,96 333.44% | 4,14 | 4,07 | 2,29 | 5,27 | 6,90 | 10,4 | 9,17 | 14,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,40 -6,13 44.54% | -15,9 -9,30 -70.7% | -5,25 -18,7 71.98% | -3,67 -21,1 82.64% | -5,64 -12,2 53.7% | -15,9 -14,3 -11.13% | -137 -11,3 -1116.89% | -7,03 -8,04 12.52% | -4,19 | -6,29 | -8,96 | -4,99 | -2,57 | 1,01 | -0,13 | 5,51 |
Net income Million USD | Released Forecast Spread | -20,8 -5,20 -299.63% | -11,2 -7,89 -42.34% | -4,93 -14,7 66.54% | -1,47 -12,3 88.04% | 3,38 -10,2 133.05% | -15,7 -11,4 -38.18% | -137 -7,80 -1655.04% | -6,58 -6,85 3.91% | -4,26 | -6,68 | -8,63 | -5,78 | -4,02 | -3,10 | -3,95 | 0,09 |
EPS USD | Released Forecast Spread | -0,28 -0,07 -286.21% | -0,15 -0,12 -30.43% | -0,07 -0,22 67.44% | -0,02 -0,15 86.3% | 0,06 -0,17 135.71% | -0,28 -0,21 -35.92% | -2,47 -0,18 -1287.64% | -0,12 -0,12 -3.45% | -0,12 | -0,14 | -0,18 | -0,12 | -0,08 | -0,06 | -0,08 | 0,00 |
Announcement Date | 14/11/22 | 08/02/23 | 09/05/23 | 08/08/23 | 13/11/23 | 07/02/24 | 08/05/24 | 06/08/24 | - | - | - | - | - | - | - | - |
Past sector events for Azenta, Inc.
2024-09-09 16:01 | ABIVAX: Q2 2024 Earnings Release |
2024-09-05 02:00 | GENUS PLC: Q4 2024 Earnings Release |
2024-08-29 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q2 2024 Earnings Release |
2024-08-29 02:00 | BIOARCTIC AB: Q2 2024 Earnings Release |
2024-08-28 19:27 | MESOBLAST LIMITED: Q4 2024 Earnings Release |
2024-08-28 | R&G PHARMASTUDIES CO., LTD.: Q2 2024 Earnings Release |
2024-08-28 | MORPHOSYS AG: Q2 2024 Earnings Release |
2024-08-28 02:00 | PURETECH HEALTH PLC: Q2 2024 Earnings Release |
2024-08-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q2 2024 Earnings Release |
2024-08-27 04:00 | OCULIS HOLDING AG: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AZTA Stock
- Calendar Azenta, Inc.
MarketScreener is also available in this country: United States.
Switch edition